Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
3.210
+0.320 (11.07%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Adaptive Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
-225.25-200.19-207.28-146.23-69.57-46.35-42.7
Depreciation & Amortization
29.1528.1520.9811.747.7965.8
Share-Based Compensation
62.9155.4843.2524.7613.1211.157.01
Other Operating Activities
-23.13-67.38-49.68-39.96253.1-2.96-4.83
Operating Cash Flow
-156.32-183.95-192.73-149.68205.4-32.26-34.86
Capital Expenditures
-10.7-16.35-61.75-18.8-11.2-6.3-2.21
Change in Investments
140.3419.25242.96-98.24-470.57.0438.73
Other Investing Activities
-------0.09
Investing Cash Flow
129.652.91181.21-117.04-481.70.7436.43
Share Issuance / Repurchase
2.257.8926.72293.91324.911.270.22
Debt Issued / Paid
0124.3800000
Other Financing Activities
--0.43-0.32-5-0.0249.81
Financing Cash Flow
2.25132.2727.15293.59319.921.2550.03
Net Cash Flow
-24.43-48.7815.6326.8643.62-30.2851.61
Free Cash Flow
-167.02-200.29-254.47-168.49194.2-38.56-37.07
Free Cash Flow Margin
-98.09%-108.09%-164.87%-171.26%228.28%-69.27%-96.42%
Free Cash Flow Per Share
-1.16-1.41-1.81-1.282.81-3.05-3.04
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).